Kestra Private Wealth Services LLC Sells 1,942 Shares of Veru Inc. (NASDAQ:VERU)

Kestra Private Wealth Services LLC lowered its position in Veru Inc. (NASDAQ:VERUGet Rating) by 0.6% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 315,826 shares of the company’s stock after selling 1,942 shares during the period. Kestra Private Wealth Services LLC owned about 0.39% of Veru worth $1,525,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. ProShare Advisors LLC bought a new position in Veru during the 4th quarter worth about $82,000. BNP Paribas Arbitrage SA increased its holdings in Veru by 28.1% during the 4th quarter. BNP Paribas Arbitrage SA now owns 17,830 shares of the company’s stock worth $105,000 after purchasing an additional 3,913 shares in the last quarter. Teacher Retirement System of Texas increased its holdings in Veru by 22.4% during the 4th quarter. Teacher Retirement System of Texas now owns 12,360 shares of the company’s stock worth $73,000 after purchasing an additional 2,258 shares in the last quarter. Qube Research & Technologies Ltd bought a new position in Veru during the 4th quarter worth about $73,000. Finally, Blair William & Co. IL increased its holdings in Veru by 1.6% during the 4th quarter. Blair William & Co. IL now owns 314,925 shares of the company’s stock worth $1,855,000 after purchasing an additional 5,050 shares in the last quarter. Institutional investors own 60.55% of the company’s stock.

Insider Activity at Veru

In related news, Director Mario Eisenberger sold 100,000 shares of the firm’s stock in a transaction dated Monday, August 15th. The shares were sold at an average price of $20.04, for a total value of $2,004,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 23.10% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

VERU has been the subject of several analyst reports. TheStreet cut Veru from a “c” rating to a “d” rating in a report on Thursday, August 11th. Cantor Fitzgerald raised their price objective on Veru from $24.00 to $30.00 in a report on Thursday, August 11th. Five analysts have rated the stock with a buy rating, According to MarketBeat, the company currently has an average rating of “Buy” and an average target price of $34.50.

Veru Price Performance

Shares of NASDAQ VERU opened at $14.28 on Friday. Veru Inc. has a fifty-two week low of $4.34 and a fifty-two week high of $24.55. The stock has a market capitalization of $1.14 billion, a price-to-earnings ratio of -24.20 and a beta of -0.44. The business has a 50-day moving average of $15.29 and a 200-day moving average of $11.92.

Veru Profile

(Get Rating)

Veru Inc, an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N.

Further Reading

Want to see what other hedge funds are holding VERU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veru Inc. (NASDAQ:VERUGet Rating).

Institutional Ownership by Quarter for Veru (NASDAQ:VERU)

Receive News & Ratings for Veru Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veru and related companies with MarketBeat.com's FREE daily email newsletter.